Wehrli, M., Oppliger Leibundgut, E., Gattiker, H. H., Manz, M. G., Müller, A. M., & Goede, J. S. (2017). Response to Tyrosine Kinase Inhibitors in Myeloproliferative Neoplasia with 8p11 Translocation and CEP110‐FGFR1 Rearrangement. Oncologist.
استشهاد بنمط شيكاغوWehrli, Marc, Elisabeth Oppliger Leibundgut, Heinrich H. Gattiker, Markus G. Manz, Antonia M.S Müller, و Jeroen S. Goede. "Response to Tyrosine Kinase Inhibitors in Myeloproliferative Neoplasia With 8p11 Translocation and CEP110‐FGFR1 Rearrangement." Oncologist 2017.
MLA استشهادWehrli, Marc, et al. "Response to Tyrosine Kinase Inhibitors in Myeloproliferative Neoplasia With 8p11 Translocation and CEP110‐FGFR1 Rearrangement." Oncologist 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.